middle.news
CurveBeam AI Doubles Revenue and Cuts Losses in FY25 Despite Device Validation Delays
1:54am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
CurveBeam AI Doubles Revenue and Cuts Losses in FY25 Despite Device Validation Delays
1:54am on Saturday 30th of August, 2025 AEST
Key Points
Revenue surged 86% to $12.1 million in FY25
Net loss after tax narrowed by 27% to $16.8 million
Operating loss reduced by 31% to $11.1 million
Cost reductions in HR, consultancy, and finance expenses
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Curvebeam AI (ASX:CVB)
OPEN ARTICLE